SCHEMBL15520368

SCHEMBL15520368

CC1CCC(n2ccc3c(F)cccc32)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 1/20 0.47
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ OPRM1 P35372 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ OPRL1 P41146 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ RHEB Q15382 1/20 0.35
▸ DRD2 P14416 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ GRM7 Q14831 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15520834 0.81 NOTUM (0.43) SCDMEN1KMT2AOPRM1OPRD1
SCHEMBL16821913 0.80 TOP2A (0.33) SCDHTR2AMEN1KMT2ATOP2A
SCHEMBL30962036 0.80 SCD (0.44) SCDHTR2AHTR2CMEN1KMT2A
SCHEMBL30962041 0.80 SCD (0.44) SCDHTR2AHTR2CMEN1KMT2A
SCHEMBL4989528 0.77 SCD (0.42) SCDHTR2AHTR2CLMNAALDH1A1
SCHEMBL24109872 0.76 SCD (0.41) SCDHTR2AHTR2CRHEBSLC6A4
SCHEMBL24110514 0.75 SCD (0.38) SCDHTR2AHTR2CRHEB
SCHEMBL15910593 0.71 ALDH1A1 (0.38) SCDMEN1KMT2AOPRM1OPRD1
SCHEMBL23648384 0.71 OPRM1 (0.36) SCDMEN1KMT2AOPRM1OPRD1
SCHEMBL30962038 0.71 PRKCG (0.46) MEN1KMT2AOPRM1OPRD1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024130342-A1 TRANSIENT RECEPTOR POTENTIAL VANILLOID 6 INHIBITORS UNIQUEST PTY LIMITED (AU) 2024-06-27 — — WO disclosed
US-20210032202-A1 INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF NOVARTIS INSTITUTE FOR TROPICAL DISEASES PTE LTD. (SG) 2021-02-04 — — US disclosed
US-20160355477-A1 INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF NOVARTIS AG (CH) 2016-12-08 — — US disclosed
US-9447039-B2 Indole carboxamide derivatives and uses thereof NOVARTIS AG (CH) 2016-09-20 — — US disclosed
EP-2892880-A1 INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF Novartis AG (CH) 2015-07-15 — — EP disclosed
US-20150175539-A1 INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF NOVARTIS AG (CH) 2015-06-25 — — US disclosed
WO-2014037900-A1 INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF NOVARTIS AG (CH) 2014-03-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175539-A1 INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF TPH1, TPH2, IARS2 SCD 2172/4885HTR2A 111/4885HTR2C 143/4885
US-20210032202-A1 INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF TPH1, TPH2, IARS2 SCD 1976/4885HTR2A 107/4885HTR2C 138/4885
US-20160355477-A1 INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF TPH1, TPH2, IARS2 SCD 2172/4885HTR2A 111/4885HTR2C 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback